Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Canadian Journal of Physiology and Pharmacology|April 16, 2010
Zinc-metallothionein: a potential mediator of antioxidant defence mechanisms in response to dopamine-induced stressJoseph K Eibl, Zouleika Abdallah, Gregory M Ross
Drug and Alcohol Dependence|August 1, 2018
Improved treatment-retention for patients receiving methadone dosing within the clinic providing physician and other health services (onsite) versus dosing at community (offsite) pharmaciesGraham Gauthier, Joseph K Eibl, David C Marsh
Neurochemistry International|October 30, 2012
Structural, biological, and pharmacological strategies for the inhibition of nerve growth factorJoseph K Eibl, Bridget C Strasser, Gregory M Ross
European Journal of Pharmacology|March 27, 2013
Identification of novel pyrazoloquinazolinecarboxilate analogues to inhibit nerve growth factor in vitroJoseph K Eibl, Bridget C Strasser, Gregory M Ross
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|May 26, 2017
[Newly occurring loss of visual acuity in choroidal osteoma]A Schuh, P Foerster, S Priglinger, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2009
Multipotent neurotrophin antagonist targets brain-derived neurotrophic factor and nerve growth factorJ K Eibl, S A Chapelsky, G M Ross
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 20, 2017
The State of Opioid Agonist Therapy in Canada 20 Years after Federal OversightJoseph K Eibl, Kristen Morin, Esa Leinonen, et al.
Substance Abuse Treatment, Prevention, and Policy|September 21, 2016
Too much or never enough: a response to Treatment of opioid disorders in Canada: looking at the 'other epidemic'Joseph K Eibl, Kristen A Morin-Taus, David C Marsh
The International Journal on Drug Policy|January 1, 2021
Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, CanadaKristen A Morin, Shreedhar Acharya, Joseph K Eibl, et al.
European Addiction Research|March 11, 2021
A Retrospective Cohort Study Comparing In-Person and Telemedicine-Based Opioid Agonist Treatment in Ontario, Canada, Using Administrative Health DataKristen A Morin, Matthiew D Parrotta, Joseph K Eibl, et al.
Pageof 7